Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 2/20 | 0.46 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.46 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.46 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | HTR7 | P34969 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2093881 | 0.88 | HTR1A (0.52) | LTA4HHTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL18171347 | 0.87 | TP53 (0.53) | LTA4HCA1CA2FAAHCNR2 | |
| SCHEMBL27984159 | 0.87 | ALDH1A1 (0.53) | LTA4HCA12CA1CA2CA4 | |
| Water SCHEMBL28213281 | 0.85 | TP53 (0.52) | LTA4HCA1CA2FAAHCNR2 | |
| SCHEMBL6536167 | 0.84 | ERN1 (0.53) | LTA4HFAAHCNR2HTR1AADRA1D | |
| SCHEMBL6299863 | 0.84 | HSP90AA1 (0.50) | LTA4HFAAHCNR2HTR1AADRA1D | |
| SCHEMBL6300999 | 0.84 | HSP90AA1 (0.50) | LTA4HFAAHCNR2HTR1AADRA1D | |
| SCHEMBL5250993 | 0.84 | CA2 (0.55) | CA12CA1CA2CA4CA7 | |
| SCHEMBL4814597 | 0.83 | TUBB1 (0.42) | LTA4HCA12CA1CA2CA4 | |
| SCHEMBL20767517 | 0.82 | FAAH (0.43) | LTA4HCA12CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115385956-A | Biaryl diphosphine ligands and transition metal complexes thereof | 东莞市均成高新材料有限公司 | 2022-11-25 | — | — | CN | disclosed |
| US-10233135-B2 | Process for preparing perhydrofluorene or alkyl-substituted perhydrofluorene | TIANJIN UNIVERSITY (CN) | 2019-03-19 | — | — | US | disclosed |
| US-20190031576-A1 | A Process for Preparing Perhydrofluorene or Alkyl-Substituted Perhydrofluorene | TIANJIN UNIVERSITY (CN) | 2019-01-31 | — | — | US | disclosed |
| US-7824715-B2 | Perfume compositions | QUEST INTERNATIONAL B. V. (NL) | 2010-11-02 | — | — | US | disclosed |
| US-20080255024-A1 | Mixture containing relaxing odors | QUEST INTERNATIONAL B.V. | 2008-10-16 | — | — | US | disclosed |
| EP-1343466-B1 | PERFUME COMPOSITIONS | QUEST INT SERV BV (NL) | 2007-01-03 | — | — | EP | disclosed |
| US-20040063604-A1 | Perfume compositions | QUEST INTERNATIONAL B.V. (NL) | 2004-04-01 | — | — | US | disclosed |
| US-6673813-B2 | INHIBITING MEMBRANE TRANSPORT MEDIATED BY THE MULTIDRUG RESISTANCE ASSOCIATED PROTEIN MRP IN A PATIENT BY ADMINISTERING A COMPOUND HAVING AN AMPHIPHILIC ANION AND A MOLECULAR WEIGHT OF FROM 300 TO 950 DALTONS. | JEDLITSCHKY GABRIELE (DE) | 2004-01-06 | — | — | US | disclosed |
| EP-1343466-A1 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL B.V. (NL) | 2003-09-17 | — | — | EP | disclosed |
| WO-2002049600-A1 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL B.V. (NL) | 2002-06-27 | — | — | WO | disclosed |
| EP-1129707-A2 | Methods for identifying and treating resistant tumors | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2001-09-05 | — | — | EP | disclosed |
| US-6235785-B1 | DRUG RESISTANCE | ELI LILLY AND COMPANY | 2001-05-22 | — | — | US | disclosed |
| EP-0544488-B1 | Substituted phenyl phenol leukotriene antagonists | LILLY CO ELI (US) | 1998-03-11 | — | — | EP | disclosed |
| EP-0777472-A2 | METHODS FOR IDENTIFYING AND TREATING RESISTANT TUMORS | ELI LILLY AND COMPANY (US) | 1997-06-11 | — | — | EP | disclosed |
| WO-1996036347-A1 | USE OF LEUKOTRIENE ANTAGONISTS FOR ALZHEIMER'S DISEASE | ELI LILLY AND COMPANY (US) | 1996-11-21 | — | — | WO | disclosed |
| EP-0743064-A1 | Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease | ELI LILLY AND COMPANY (US) | 1996-11-20 | — | — | EP | disclosed |
| US-5543428-A | ADMINISTERING SUBSTITUTED PHENOXYALKYL COMPOUNDS TO REVERSE DRUG RESISTANCE | ELI LILLY AND COMPANY (US) | 1996-08-06 | — | — | US | disclosed |
| WO-1996006604-A2 | METHODS FOR IDENTIFYING AND TREATING RESISTANT TUMORS | ELI LILLY AND COMPANY (US) | 1996-03-07 | — | — | WO | disclosed |
| US-5462954-A | Antiinflammatory, antiallergens; treating asthma | ELI LILLY AND COMPANY (US) | 1995-10-31 | — | — | US | disclosed |
| EP-0544488-A2 | Substituted phenyl phenol leukotriene antagonists | ELI LILLY AND COMPANY (US) | 1993-06-02 | — | — | EP | disclosed |